Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7830)
All Articles published online
|
Publishing Process of This Article
|
Nov 26, 2014 (publication date) through Dec 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Stem Cells
ISSN
1948-0210
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wolfson B, Eades G, Zhou Q. Roles of microRNA-140 in stem cell-associated early stage breast cancer. World J Stem Cells 2014; 6(5): 591-597 [PMID: 25426255 DOI: 10.4252/wjsc.v6.i5.591] |
|---|---|
| URL: | https://www.wjgnet.com/1948-0210/full/v6/i5/591.htm |
| Number | Citing Articles |
| 1 |
Soudeh Ghafouri-Fard, Vahid Niazi, Mohammad Taheri. Role of miRNAs in conveying message of stem cells via extracellular vesicles. Experimental and Molecular Pathology 2020; 117: 104569 doi: 10.1016/j.yexmp.2020.104569
|
| 2 |
Zuwen Zhang, Benjamin Trautz, Damir Kračun, Frederick Vogel, Michael Weitnauer, Katharina Hochkogler, Andreas Petry, Agnes Görlach. Stabilization of p22phox by Hypoxia Promotes Pulmonary Hypertension. Antioxidants & Redox Signaling 2019; 30(1): 56 doi: 10.1089/ars.2017.7482
|
| 3 |
Yasutaka Yamada, Mayuko Kato, Takayuki Arai, Hiroki Sanada, Akifumi Uchida, Shunsuke Misono, Shinichi Sakamoto, Akira Komiya, Tomohiko Ichikawa, Naohiko Seki. Aberrantly expressed PLOD1 promotes cancer aggressiveness in bladder cancer: a potential prognostic marker and therapeutic target. Molecular Oncology 2019; 13(9): 1898 doi: 10.1002/1878-0261.12532
|
| 4 |
Haifei He, Wei Tian, Hailong Chen, Kai Jiang. MiR-944 functions as a novel oncogene and regulates the chemoresistance in breast cancer. Tumor Biology 2016; 37(2): 1599 doi: 10.1007/s13277-015-3844-x
|
| 5 |
R Venkatadri, T Muni, A K V Iyer, J S Yakisich, N Azad. Role of apoptosis-related miRNAs in resveratrol-induced breast cancer cell death. Cell Death & Disease 2016; 7(2): e2104 doi: 10.1038/cddis.2016.6
|
| 6 |
Raquel Nogueras Pérez, Noelia Heredia-Nicolás, Laura de Lara-Peña, Julia López de Andrés, Juan Antonio Marchal, Gema Jiménez, Carmen Griñán-Lisón. Unraveling the Potential of miRNAs from CSCs as an Emerging Clinical Tool for Breast Cancer Diagnosis and Prognosis. International Journal of Molecular Sciences 2023; 24(21): 16010 doi: 10.3390/ijms242116010
|
| 7 |
Dawei Wu, Jun Zhang, Ying Lu, Song Bo, Lianhong Li, Lu Wang, Qingqing Zhang, Jun Mao. miR-140-5p inhibits the proliferation and enhances the efficacy of doxorubicin to breast cancer stem cells by targeting Wnt1. Cancer Gene Therapy 2019; 26(3-4): 74 doi: 10.1038/s41417-018-0035-0
|
| 8 |
Xiantao Sun, Zhimin Wang, Weitang Yuan. Down-regulated long non-coding RNA SNHG1 inhibits tumor genesis of colorectal carcinoma. Cancer Biomarkers 2017; 20(1): 67 doi: 10.3233/CBM-170112
|
| 9 |
Margot Zöller. Cancer Gene Profiling. Methods in Molecular Biology 2016; 1381: 111 doi: 10.1007/978-1-4939-3204-7_7
|
| 10 |
Yunjie He, Fei Deng, Shujie Zhao, Shanliang Zhong, Jianhua Zhao, Dandan Wang, Xiu Chen, Jian Zhang, Junchen Hou, Wei Zhang, Li Ding, Jinhai Tang, Zuomin Zhou. Analysis of miRNA–mRNA Network Reveals miR-140-5p as a Suppressor of Breast Cancer Glycolysis Via Targeting GLUT1. Epigenomics 2019; 11(9): 1021 doi: 10.2217/epi-2019-0072
|
| 11 |
Jiamin Wei, Zhenguo Liu, Kaiming Wu, Dongjie Yang, Yulong He, George Gong Chen, Jian Zhang, Jianhua Lin. Identification of prognostic and subtype-specific potential miRNAs in thymoma. Epigenomics 2017; 9(5): 647 doi: 10.2217/epi-2016-0161
|
| 12 |
Nafiseh Payervand, Katayoon Pakravan, Ehsan Razmara, Kailash Kumar Vinu, Sara Ghodsi, Masoumeh Heshmati, Sadegh Babashah. Exosomal circ_0084043 derived from colorectal cancer-associated fibroblasts promotes in vitro endothelial cell angiogenesis by regulating the miR-140–3p/HIF-1α/VEGF signaling axis. Heliyon 2024; 10(11): e31584 doi: 10.1016/j.heliyon.2024.e31584
|
| 13 |
Ke Liu, Yi Hou, Yunke Liu, Jia Zheng. LncRNA SNHG15 contributes to proliferation, invasion and autophagy in osteosarcoma cells by sponging miR-141. Journal of Biomedical Science 2017; 24(1) doi: 10.1186/s12929-017-0353-9
|
| 14 |
Wenyi Qin, Santanu Dasgupta, John Corradi, Edward R. Sauter. Human Milk and Matched Serum Demonstrate Concentration of Select miRNAs. Breastfeeding Medicine 2017; 12(1): 63 doi: 10.1089/bfm.2016.0108
|
| 15 |
Mai Mohamed Nabil, Maha Imam Ahmed, Muneera Al-Sheeha, Walaa Ahmed Yousry, Dalia Abdel Wahab Mohamed. The negative correlation between miR-140-3-p and Metadherin gene in estrogen and progesterone receptor positive–breast cancer. Gene Reports 2021; 23: 101068 doi: 10.1016/j.genrep.2021.101068
|
| 16 |
Lei Wang, Zeng Jin, Rohan P. Master, Chandra K. Maharjan, Madison E. Carelock, Tiffany B. A. Reccoppa, Myung-Chul Kim, Ryan Kolb, Weizhou Zhang. Breast Cancer Stem Cells: Signaling Pathways, Cellular Interactions, and Therapeutic Implications. Cancers 2022; 14(13): 3287 doi: 10.3390/cancers14133287
|
| 17 |
Morteza Jafarinia, Fereshteh Alsahebfosoul, Hossein Salehi, Nahid Eskandari, Mazdak Ganjalikhani-Hakemi. Mesenchymal Stem Cell-Derived Extracellular Vesicles: A Novel Cell-Free Therapy. Immunological Investigations 2020; 49(7): 758 doi: 10.1080/08820139.2020.1712416
|
| 18 |
Rui Gu, Yi-Fu Sun, Min-Fei Wu, Jia-Bei Liu, Jin-Lan Jiang, Shuai-Hua Wang, Xin-Lei Wang, Qiang Guo. Biological roles of microRNA-140 in tumor growth, migration, and metastasis of osteosarcoma in vivo and in vitro. Tumor Biology 2016; 37(1): 353 doi: 10.1007/s13277-015-3801-8
|
| 19 |
Jeremy T-H. Chang, Fan Wang, William Chapin, R. Stephanie Huang, Bibekanand Mallick. Identification of MicroRNAs as Breast Cancer Prognosis Markers through the Cancer Genome Atlas. PLOS ONE 2016; 11(12): e0168284 doi: 10.1371/journal.pone.0168284
|
| 20 |
Tejveer Singh, Mahesh Kaushik, Lokesh Chandra Mishra, Chesta Behl, Vijay Singh, Hardeep Singh Tuli. Exosomal miRNAs as novel avenues for breast cancer treatment. Frontiers in Genetics 2023; 14 doi: 10.3389/fgene.2023.1134779
|
| 21 |
Tong Sun, Yan Song, Hong Yu, Xiao Luo. RETRACTED ARTICLE: Identification of lncRNA TRPM2-AS/miR-140-3p/PYCR1 axis’s proliferates and anti-apoptotic effect on breast cancer using co-expression network analysis. Cancer Biology & Therapy 2019; 20(6): 760 doi: 10.1080/15384047.2018.1564563
|
| 22 |
Saghar Yousefnia, Farzad Seyed Forootan, Shiva Seyed Forootan, Mohammad Hossein Nasr Esfahani, Ali Osmay Gure, Kamran Ghaedi. Mechanistic Pathways of Malignancy in Breast Cancer Stem Cells. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.00452
|
| 23 |
Jesús Morillo-Bernal, Patricia Pizarro-García, Gema Moreno-Bueno, Amparo Cano, María J. Mazón, Pilar Eraso, Francisco Portillo. HuR (ELAVL1) Stabilizes SOX9 mRNA and Promotes Migration and Invasion in Breast Cancer Cells. Cancers 2024; 16(2): 384 doi: 10.3390/cancers16020384
|
| 24 |
Kai Song, Maryam Farzaneh. Signaling pathways governing breast cancer stem cells behavior. Stem Cell Research & Therapy 2021; 12(1) doi: 10.1186/s13287-021-02321-w
|
| 25 |
Omar Salem, Nese Erdem, Janine Jung, Ewald Münstermann, Angelika Wörner, Heike Wilhelm, Stefan Wiemann, Cindy Körner. The highly expressed 5’isomiR of hsa-miR-140-3p contributes to the tumor-suppressive effects of miR-140 by reducing breast cancer proliferation and migration. BMC Genomics 2016; 17(1) doi: 10.1186/s12864-016-2869-x
|
| 26 |
WENJUN YIN, YUEHUA NIE, ZHIWEI ZHANG, LIMING XIE, XIUSHENG HE. miR-193b acts as a cisplatin sensitizer via the caspase-3-dependent pathway in HCC chemotherapy. Oncology Reports 2015; 34(1): 368 doi: 10.3892/or.2015.3996
|
| 27 |
Narasimha M. Beeraka, Shalini H. Doreswamy, Surya P. Sadhu, Asha Srinivasan, Rajeswara Rao Pragada, SubbaRao V. Madhunapantula, Gjumrakch Aliev. The Role of Exosomes in Stemness and Neurodegenerative Diseases—Chemoresistant-Cancer Therapeutics and Phytochemicals. International Journal of Molecular Sciences 2020; 21(18): 6818 doi: 10.3390/ijms21186818
|
| 28 |
Y Lu, T Qin, J Li, L Wang, Q Zhang, Z Jiang, J Mao. MicroRNA-140-5p inhibits invasion and angiogenesis through targeting VEGF-A in breast cancer. Cancer Gene Therapy 2017; 24(9): 386 doi: 10.1038/cgt.2017.30
|
| 29 |
Olga A. Sukocheva, Elena Lukina, Markus Friedemann, Mario Menschikowski, Albert Hagelgans, Gjumrakch Aliev. The crucial role of epigenetic regulation in breast cancer anti-estrogen resistance: Current findings and future perspectives. Seminars in Cancer Biology 2022; 82: 35 doi: 10.1016/j.semcancer.2020.12.004
|
| 30 |
Lihui Yu, Ying Lu, Xiaocui Han, Wenyue Zhao, Jiazhi Li, Jun Mao, Bo Wang, Jie Shen, Shujun Fan, Lu Wang, Mei Wang, Lianhong Li, Jianwu Tang, Bo Song. RETRACTED ARTICLE: microRNA -140-5p inhibits colorectal cancer invasion and metastasis by targeting ADAMTS5 and IGFBP5. Stem Cell Research & Therapy 2016; 7(1) doi: 10.1186/s13287-016-0438-5
|
| 31 |
Lingli Hou, Qi Liu, Ying Zhao, Hongwei Yang, Qingying Meng, Fei Yu. MicroRNA-140-5p inhibits cellular proliferation, migration and invasion by downregulating AKT/STAT3/NF-κB pathway in breast carcinoma cells. Acta Pharmaceutica 2022; 72(4): 587 doi: 10.2478/acph-2022-0039
|
| 32 |
Sidney W. Fu, Woojin Lee, Caitrin Coffey, Alexa Lean, Xiaoling Wu, Xiaohui Tan, Yan-gao Man, Rachel F. Brem. miRNAs as potential biomarkers in early breast cancer detection following mammography. Cell & Bioscience 2016; 6(1) doi: 10.1186/s13578-016-0071-0
|
| 33 |
Yongjia Yin, Cheng Shen, Pan Xie, Zeneng Cheng, Qubo Zhu. Construction of an initial microRNA regulation network in breast invasive carcinoma by bioinformatics analysis. The Breast 2016; 26: 1 doi: 10.1016/j.breast.2015.11.008
|
| 34 |
Tieying Hou, Long Ye, Shulin Wu. Knockdown of LINC00504 Inhibits the Proliferation and Invasion of Breast Cancer via the Downregulation of miR-140-5p. OncoTargets and Therapy 2021; : 3991 doi: 10.2147/OTT.S294965
|
| 35 |
Li-Bo Tang, Shu-Xin Ma, Zhuo-Hui Chen, Qi-Yuan Huang, Long-Yuan Wu, Yi Wang, Rui-Chen Zhao, Li-Xia Xiong. Exosomal microRNAs: Pleiotropic Impacts on Breast Cancer Metastasis and Their Clinical Perspectives. Biology 2021; 10(4): 307 doi: 10.3390/biology10040307
|
| 36 |
Amir Sadra Zangouei, Maliheh Alimardani, Meysam Moghbeli. MicroRNAs as the critical regulators of Doxorubicin resistance in breast tumor cells. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-01873-4
|
| 37 |
Tong Liu, Kebang Hu, Zuowei Zhao, Guanglei Chen, Xunyan Ou, Hao Zhang, Xin Zhang, Xiaofei Wei, Dan Wang, Meizi Cui, Caigang Liu. MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt/β-catenin pathway. Oncotarget 2015; 6(39): 41638 doi: 10.18632/oncotarget.5873
|
| 38 |
Yangbai Sun, Nengbin He, Yang Dong, Chaoyin Jiang. MiR-24-BIM-Smac/DIABLO axis controls the sensitivity to doxorubicin treatment in osteosarcoma. Scientific Reports 2016; 6(1) doi: 10.1038/srep34238
|
| 39 |
Amrita Kundu, Joginder Singh, Jayanta Kumar Pal, Shubhra Sankar Ray. Predicting drug-resistant miRNAs in cancer. Network Modeling Analysis in Health Informatics and Bioinformatics 2022; 12(1) doi: 10.1007/s13721-022-00398-8
|
| 40 |
Abdul Khan, Eiman Ahmed, Noor Elareer, Kulsoom Junejo, Martin Steinhoff, Shahab Uddin. Role of miRNA-Regulated Cancer Stem Cells in the Pathogenesis of Human Malignancies. Cells 2019; 8(8): 840 doi: 10.3390/cells8080840
|
| 41 |
Chun-Ming Zhao, Lin-Lin Li, Jia-Wen Xu, Zhi-Wei Li, Peng Shi, Rui Jiang. LINC00092 Suppresses the Malignant Progression of Breast Invasive Ductal Carcinoma Through Modulating SFRP1 Expression by Sponging miR-1827. Cell Transplantation 2022; 31 doi: 10.1177/09636897221086967
|
| 42 |
Justin T. Roberts, Dillon G. Patterson, Valeria M. King, Shivam V. Amin, Caroline J. Polska, Dominika Houserova, Aline Crucello, Emmaline C. Barnhill, Molly M. Miller, Timothy D. Sherman, Glen M. Borchert. ADAR Mediated RNA Editing Modulates MicroRNA Targeting in Human Breast Cancer. Processes 2018; 6(5): 42 doi: 10.3390/pr6050042
|
| 43 |
Na-Kyeong Lee, Vinoth Kumar Kothandan, Sangeetha Kothandan, Youngro Byun, Seung-Rim Hwang. Exosomes and Cancer Stem Cells in Cancer Immunity: Current Reports and Future Directions. Vaccines 2021; 9(5): 441 doi: 10.3390/vaccines9050441
|
| 44 |
Jun Ma, Ping Wang, Yilong Yao, Yunhui Liu, Zhen Li, Xiaobai Liu, Zhiqing Li, Xihe Zhao, Zhuo Xi, Hao Teng, Jing Liu, Yixue Xue. Knockdown of long non-coding RNA MALAT1 increases the blood–tumor barrier permeability by up-regulating miR-140. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 2016; 1859(2): 324 doi: 10.1016/j.bbagrm.2015.11.008
|
| 45 |
Takahiro Ochiya, Kazuki Hashimoto, Akihiko Shimomura. Prospects for liquid biopsy using microRNA and extracellular vesicles in breast cancer. Breast Cancer 2024; doi: 10.1007/s12282-024-01563-9
|
| 46 |
Tong Niu, Weiwei Zhang, Wei Xiao. MicroRNA regulation of cancer stem cells in the pathogenesis of breast cancer. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-020-01716-8
|
| 47 |
Hussam S. Eltoukhy, Garima Sinha, Caitlyn A. Moore, Marina Gergues, Pranela Rameshwar. Secretome within the bone marrow microenvironment: A basis for mesenchymal stem cell treatment and role in cancer dormancy. Biochimie 2018; 155: 92 doi: 10.1016/j.biochi.2018.05.018
|
| 48 |
Junyi Wu, Zhen Qu, Zi-Wei Fei, Jun-Hua Wu, Chun-Ping Jiang. Role of stem cell-derived exosomes in cancer. Oncology Letters 2017; 13(5): 2855 doi: 10.3892/ol.2017.5824
|
| 49 |
Nur Duale, Dag M. Eide, Maria L. Amberger, Anne Graupner, Dag A. Brede, Ann K. Olsen. Using prediction models to identify miRNA-based markers of low dose rate chronic stress. Science of The Total Environment 2020; 717: 137068 doi: 10.1016/j.scitotenv.2020.137068
|
| 50 |
Chenchen Huang, Jianfa Li, Xiaoting Zhang, Tiefu Xiong, Jing Ye, Jing Yu, Yaoting Gui. The miR‐140‐5p/KLF9/KCNQ1 axis promotes the progression of renal cell carcinoma. The FASEB Journal 2020; 34(8): 10623 doi: 10.1096/fj.202000088RR
|
| 51 |
V. I. Loginov, E. A. Filippova, S. V. Kurevlev, M. V. Fridman, A. M. Burdennyy, E. A. Braga. Suppressive and Hypermethylated MicroRNAs in the Pathogenesis of Breast Cancer. Russian Journal of Genetics 2018; 54(7): 770 doi: 10.1134/S1022795418070086
|